XML 70 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes
The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income from continuing operations before income taxes:
 Year ended December 31,
 202320222021
Segment revenues:   
U.S. dialysis   
Patient service revenues:   
External sources$10,823,525 $10,488,327 $10,551,106 
Intersegment revenues88,222 87,045 90,512 
U.S. dialysis patient service revenues10,911,747 10,575,372 10,641,618 
Other revenues
External sources25,251 24,447 25,061 
Intersegment revenues— (10)284 
Total U.S. dialysis revenues10,936,998 10,599,809 10,666,963 
Other - Ancillary services
Patient service revenues751,416 688,137 662,409 
Other external sources539,955 408,983 380,221 
Intersegment revenues7,852 4,206 4,294 
Total ancillary services1,299,223 1,101,326 1,046,924 
Total net segment revenues12,236,221 11,701,135 11,713,887 
Elimination of intersegment revenues(96,074)(91,241)(95,090)
Consolidated revenues$12,140,147 $11,609,894 $11,618,797 
Segment operating margin (loss):
U.S. dialysis$1,774,578 $1,565,310 $1,974,988 
Other - Ancillary services(1)
(8,747)(96,579)(66,003)
Total segment margin1,765,831 1,468,731 1,908,985 
Reconciliation of segment operating margin to consolidated income from
 continuing operations before income taxes:
Corporate administrative support(163,047)(129,669)(111,615)
Consolidated operating income1,602,784 1,339,062 1,797,370 
Debt expense(398,551)(357,019)(285,254)
Debt extinguishment and modification costs(7,962)— — 
Other (loss) income, net(19,177)(15,765)6,378 
Income from continuing operations before income taxes$1,177,094 $966,278 $1,518,494 
 
(1)Segment operating loss for Other - Ancillary services includes equity investment loss of $2,103, $1,898 and $3,177 in 2023, 2022 and 2021, respectively.
Summary of Depreciation and Amortization Expense by Segment
Depreciation and amortization expense by reportable segment was as follows:
 Year ended December 31,
 202320222021
U.S. dialysis$695,674 $690,949 $642,711 
Other - Ancillary services49,769 41,653 37,904 
 $745,443 $732,602 $680,615 
Summary of Expenditures for Property and Equipment by Segment
Expenditures for property and equipment by reportable segment were as follows: 
 Year ended December 31,
 202320222021
U.S. dialysis$501,149 $533,600 $589,662 
Other - Ancillary services66,836 69,829 51,803 
 $567,985 $603,429 $641,465